Sorry again Baoqing, I cannot answer this one. I am still working on getting the example from the publication to work, and I am trying to back everything up right now before I finish that.
-
-
Thanks a lot!
I will also keep working on mine and keep this post updated periodically.Comment
-
Ok, problem solved.
Two things need to be considered
1 when name your samples "alphabet+ numbers" always help！
2 In case of error, you need to delete cuffData.db in the folder before re-run it.Comment
-
What do you mean Baoqing when you say, "2. In case of error, you need to delete cuffData.db in the folder before re-run it."?
I didn't do #1 at first and had problems. So I re-ran the cuffdiff command with alphabet+numbers, and got the error message, "Error in .local(object, x, y, logMode, pseudocount, labels, smooth, ...) :"
What command do I use to "delete the cuffData.db"?
Thank you!Comment
-
Are you saying, delete cuffData.db in linux or R?Comment
-
Okay. Got it. I needed to delete the cuffData.db in linux before I ran the cuffdiff command again. Thank you.Comment
-
sorry for the late response. can you at least load the library?
i found that if you had tried to read your data before the library properly loaded, the generated cuffData.db is going to intervene your next new run. you can just going into the directory and delete it, i was using R in my ubuntu.Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment